Investigating the Pharmacokinetic Characteristics of HIP1402 in Healthy Male Volunteers

Phase 1 Completed 24 enrolled Hanmi Pharmaceutical Company Limited

RandomizedCrossoverOpen-labelTreatment

Summary

To investigate the PK charateristics and the effect of food on the PK in healthy male volunteers who receive HIP1402 capsule in fed versus fasted condition

Timeline

Start: 2015-09
Primary completion: 2015-10
Completion: 2015-10

Publications

Ban MS, Kim YK, Kim B, Jung J, Kim YI, Oh J, Yu KS. Evaluation of the pharmacokinetics and food effects of a novel formulation tamsulosin 0.4 mg capsule compared with a 0.2 mg capsule in healthy male volunteers. Transl Clin Pharmacol. 2020 Dec;28(4):181-188. doi: 10.12793/tcp.2020.28.e17. Epub 2020 Nov 24.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Tamsulosin	Other / unclassified	0.2 mg	—
Subject	Tamsulosin	Other / unclassified	0.4 mg	—

Indications

No indication recorded.